- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06836375
Pilot Study for the Application of Low Power External Bioelectronic Devices in the Diagnosis of Bronchial Asthma.
Estudio Piloto Para la aplicación de Dispositivos bioelectrónicos Externos de Baja Potencia en el diagnóstico de Asma Bronquial
Study Overview
Status
Conditions
Detailed Description
The objective of this project is to detect acoustic signals generated by the respiratory system in patients with asthma using the acoustic sensor; and then, retrospectively, to use these signals to carry out signal processing research, with the aim of trying to identify signal characteristics that can be used to differentiate asthma patients from people who do not have the disease.
The hypothesis, therefore, is that it is possible to target through external smart bioelectronic devices and wireless connectivity (wearables) the initial signals of the pathophysiology of bronchial asthma and differentiate them from the signals of the normal respiratory physiology of a healthy individual.
Similarly, detection of such signals would not only be useful for asthma diagnosis but also for monitoring and early detection of exacerbations before they can be detected by the usual respiratory functional tests.
The patients will first visit the asthma unit where the diagnostic tests will be undertaken. Then the subjects will take the acoustic sensor home with them and wear it during sleep for at least two weeks.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Orsina Dessi
- Phone Number: +44 7721877020
- Email: orsina@acurable.com
Study Locations
-
-
-
Sevilla, Spain
- Hospital Virgen del Rocío
-
Contact:
- Mireia Munoz Rojo
- Phone Number: +44 0208 1917590
- Email: mireia.munoz-rojo@acurable.com
-
Principal Investigator:
- M. Auxiliadora Romero Falcon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or female, aged >= 18 and < 65.
- Ability to access applications on mobile device, technical understanding and minimal technological skills
- Subject has provided informed consent and is willing to comply with the study procedures.
Exclusion Criteria:
- Subject does not consent to the study
- Subject does not comply with inclusion criteria
- Subject has a known allergy to medical adhesives
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients with Bronchial asthma
Patients with a diagnosis of bronchial asthma, under follow-up by the Asthma Unit.
|
this test measures how much air you can breathe in and out of your lungs, as well as how easily and fast you can then blow the air out of your lungs
test used to diagnose asthma where the patient breaths in methacholine
test that uses sound waves to measure how much resistance there is to the normal movement of air in and out of your lungs when you are breathing at rest
Measure the level of nitric oxide in parts per billion (PPB) in the air the patient slowly exhales
|
|
Patients referred for consultation
Patients referred for consultation due to clinical suspicion of bronchial asthma.
|
this test measures how much air you can breathe in and out of your lungs, as well as how easily and fast you can then blow the air out of your lungs
test used to diagnose asthma where the patient breaths in methacholine
test that uses sound waves to measure how much resistance there is to the normal movement of air in and out of your lungs when you are breathing at rest
Measure the level of nitric oxide in parts per billion (PPB) in the air the patient slowly exhales
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acoustic respiratory signals
Time Frame: During the diagnostic tests performed and during the night studies performed by the participant for at least two weeks
|
Acoustic signals during the tests performed for asthma diagnosis and while the subjects sleep for at least two weeks.
|
During the diagnostic tests performed and during the night studies performed by the participant for at least two weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Immune System Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Bronchial Diseases
- Lung Diseases, Obstructive
- Respiratory Hypersensitivity
- Hypersensitivity, Immediate
- Hypersensitivity
- Asthma
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Neurotransmitter Agents
- Respiratory System Agents
- Cholinergic Agents
- Cholinergic Agonists
- Parasympathomimetics
- Muscarinic Agonists
- Miotics
- Bronchoconstrictor Agents
- Methacholine Chloride
Other Study ID Numbers
- 1914-N-22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma Bronchiale
-
Chiesi Slovenija, d.o.o.RecruitingAsthma | Asthma Bronchiale | Asthma PatientsSlovenia
-
Mundipharma Research LimitedCompletedAsthma BronchialeUnited Kingdom
-
Mundipharma Research LimitedCompletedAsthma BronchialePoland, Romania, Netherlands, United Kingdom, Germany, Hungary
-
Trakya UniversityNot yet recruiting
-
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...Active, not recruitingAsthma BronchialeItaly
-
Chiesi BulgariaCONVEX CROCompletedAsthma | Asthma Bronchiale | Asthma PatientsBulgaria
-
University of SaskatchewanNot yet recruitingAsthma BronchialeCanada
-
Schön Klinik Berchtesgadener LandBosch Healthcare Solutions GmbHCompletedAsthma Bronchiale | Asthmatic Patients | AsthmaticsGermany
-
RWTH Aachen UniversityUniversity Hospital RWTH Aachen University, Aachen, Germany.CompletedFeNO | Chewing Gum | Asthma BronchialeGermany
-
Tradeflex LtdMedisol Development Kft.RecruitingCOPD | Asthma BronchialeHungary
Clinical Trials on Spirometry test with bronchodilation
-
Psykiatrien SydNaestved HospitalCompleted
-
TechnopulmNot yet recruitingPulmonary Function Testing
-
State University of New York - Upstate Medical...Mitsubishi Tanabe Pharma America Inc.Enrolling by invitation
-
University of Sao Paulo General HospitalCompleted
-
University of MichiganWithdrawnObstructive Sleep ApneaUnited States
-
University of OklahomaCompletedSilicosis | Pneumoconiosis; SilicaUnited States
-
The Leeds Teaching Hospitals NHS TrustCompletedCystic Fibrosis | COPD | Chronic Respiratory Disease | Hypoxia, Altitude | ILDUnited Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedHIV Infections | Lung Cancer | HIV Seropositivity | Lung Cancer in the HIV Patient
-
Dr Cipto Mangunkusumo General HospitalCompletedMajor Abdominal Surgery | Postoperative Pulmonary Complication | Incentive Spirometry
-
Gaziosmanpasa Research and Education HospitalCompletedSpinal Deformity | Pectus Deformity of ChestTurkey